Peer M. Schatz is an entrepreneur and executive with over 30 years of experience in the life sciences.

He is founder and managing director of PS Capital GmbH, a unit of his family office, co-founder and chairman of Resolve Biosciences GmbH, chairman of Centogene NV (Nasdaq: CNTG), supervisory board member of Siemens Healthineers AG (Frankfurt: SHL)

Prior to October 2019 Peer Schatz was Chief Executive Officer of QIAGEN N.V. QIAGEN’s sample to insight solutions provide valuable insights on molecular information to customers in molecular diagnostics, applied testing, academia and the pharmaceutical industry. Peer Schatz joined QIAGEN in 1993, when the company had under 30 employees and revenues of approximately $2 million. Under his direction, QIAGEN grew to employ more than 5,200 people in over 35 locations around the world and to record annual revenues of over US$ 1.6 billion – with strong leadership positions in molecular diagnostics/precision medicine, research tools and advanced bioinformatics. He led more than 40 acquisitions for QIAGEN as well as QIAGEN’s listings on NASDAQ (in 1996, making QIAGEN the first German company to do so) and its listings on the NYSE (2018) and the Frankfurt Stock Exchange (1997). QIAGEN had a market capitalization of around $10 billion in October 2019.